Fresenius Medical Care, the world’s largest provider of dialysis products and services, acquires a majority stake in Cura Group ("Cura"), a leading operator of high-quality day hospitals in Australia.

In its 19 private day hospitals across Australia, Cura provides a variety of specialized ambulant services, such as ophthalmology and orthopedic surgeries in an outpatient setting. Cura was established in 2008 and generated revenue of AUD 127 million (EUR 87 million) in the financial year 2015/2016.

Fresenius Medical Care is addressing activities around a coordinated care approach to treat patients in a more holistic way. As a consequence, Fresenius Medical Care is strengthening its portfolio by scaling up to around 40 outpatient facilities in the Australian market. This step allows Fresenius Medical Care to further leverage its core competence in operating outpatient facilities, extend its dialysis network and thereby also lay the foundation for future growth for the new setup in the Australian market.

This transaction is subject to remaining shareholder agreements, authority approval and will be financed through a combination of cash and debt. Fresenius Medical Care expects the investment to be accretive on operating earnings in the first year after closing.